StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Primary Care Portfolio Total [legacy] — U.S. by Year

Primary Care Portfolio Total [legacy] — U.S. ($M) ($M)

Pfizer Primary Care Portfolio Total [legacy] — U.S.: $15,898M in FY2025, down 15.4% from a year earlier.

Latest, FY2025
15,898
Period ended Dec 31, 2025
Change on a year earlier
-15.4%
18,783 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below

Where the FY2025 figure comes from

“|| Primary Care | $ | 26,820 | $ | 30,135 | (11%) | (12%) | $ | 15,898 | $ | 18,783 | (15%) | $ | 10,921 | $ | 11,352 | (4%) | (5%)”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

Reported in Form 8-K Revenue Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Pfizer Primary Care Portfolio Total [legacy] — U.S. ($M), annual FY2021–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/port-leg-pc-us

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.